Featured 420 Real Properties Located in Los Angeles | CashCropToday
0 Shares 1036 Views

Featured 420 Real Properties Located in Los Angeles

July 8, 2018
1036 Views

PRICE DROP! 15.7K SQFT in Los Angeles at $1 PSF

While it may not be the most polished property we’ve ever featured, this one is by far one of the least expensive Los Angeles M3 Blue Zone spaces we’ve seen. And, right now, you can seize the day and take advantage of this HUGE opportunity and get ready to pursue your Distribution, Delivery, Level 1 Manufacturing, Indoor Cultivation or Microbusiness (with Delivery) license.

With up to 18′ ceilings, 8 reserved parking spaces, a brick outer structure, built mezzanine with a loading ramp, concrete floors, and a wide-open floor plan, this is the blank canvas you’ve been looking for.

At 200 AMPS, you will need a power upgrade if you plan to use the space for cultivation; however, we have connected with a group of professionals who can help handle that process AND integrate creative cost-saving solutions for your power needs.

Call or email us at 949-916-0022 x407 and let us know if you’d like to book a time to see this space.

At $1 PSF, we don’t anticipate it’ll be around for long!

420 Real Properties – Paul K. Thompson – CAL BRE # 00547210

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
269 views
Market Watch
269 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
192 views
Global
192 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
189 views
Manufacturing
189 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: